BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29653366)

  • 1. Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na
    Lan YL; Wang X; Lou JC; Xing JS; Yu ZL; Wang H; Zou S; Ma X; Zhang B
    Biomed Pharmacother; 2018 Jul; 103():204-215. PubMed ID: 29653366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway.
    Lan YL; Zou YJ; Lou JC; Xing JS; Wang X; Zou S; Ma BB; Ding Y; Zhang B
    Cell Biol Toxicol; 2019 Dec; 35(6):521-539. PubMed ID: 30739221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.
    Burkard C; Verheije MH; Haagmans BL; van Kuppeveld FJ; Rottier PJ; Bosch BJ; de Haan CA
    J Virol; 2015 Apr; 89(8):4434-48. PubMed ID: 25653449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
    Huang CJ; Zhang CY; Zhao YK; Wang D; Zhuang L; Qian L; Xie L; Zhu Y; Meng ZQ
    Am J Chin Med; 2023; 51(2):461-485. PubMed ID: 36655687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.
    Yue Q; Zhen H; Huang M; Zheng X; Feng L; Jiang B; Yang M; Wu W; Liu X; Guo D
    PLoS One; 2016; 11(7):e0159034. PubMed ID: 27428326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin.
    Li H; Wang P; Gao Y; Zhu X; Liu L; Cohen L; Meng Z; Yang P
    Oncol Rep; 2011 Mar; 25(3):825-30. PubMed ID: 21181095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly.
    Sun P; Feng LX; Zhang DM; Liu M; Liu W; Mi T; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
    Acta Pharmacol Sin; 2016 Jul; 37(7):908-18. PubMed ID: 27238210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marinobufagenin inhibits glioma growth through sodium pump α1 subunit and ERK signaling-mediated mitochondrial apoptotic pathway.
    Lan YL; Wang X; Lou JC; Xing JS; Zou S; Yu ZL; Ma XC; Wang H; Zhang B
    Cancer Med; 2018 May; 7(5):2034-2047. PubMed ID: 29582577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells.
    Lefranc F; Mijatovic T; Kondo Y; Sauvage S; Roland I; Debeir O; Krstic D; Vasic V; Gailly P; Kondo S; Blanco G; Kiss R
    Neurosurgery; 2008 Jan; 62(1):211-21; discussion 221-2. PubMed ID: 18300910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
    Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a Long Non-Coding RNA, the Antisense RNA of Na/K-ATPase α1 in Human Kidney Cells.
    Fan X; Ashraf UM; Drummond CA; Shi H; Zhang X; Kumarasamy S; Tian J
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma.
    Zhuang L; Xu L; Wang P; Jiang Y; Yong P; Zhang C; Zhang H; Meng Z; Yang P
    Oncotarget; 2015 Sep; 6(29):28183-93. PubMed ID: 26334094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the Na/K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the preimplantation mouse embryo.
    Barcroft LC; Moseley AE; Lingrel JB; Watson AJ
    Mech Dev; 2004 May; 121(5):417-26. PubMed ID: 15147760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of the alpha1 subunit of Na
    Nakamura K; Shiozaki A; Kosuga T; Shimizu H; Kudou M; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
    Gastric Cancer; 2021 Nov; 24(6):1278-1292. PubMed ID: 34251542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
    Liu M; Feng LX; Sun P; Liu W; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
    PLoS One; 2016; 11(7):e0159789. PubMed ID: 27459387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.
    Okamoto T; Wu Y; Matsuhisa K; Saito A; Sakaue F; Imaizumi K; Kaneko M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):1030-1035. PubMed ID: 31732153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis by bufalin in human tumor cells is associated with a change of intracellular concentration of Na+ ions.
    Kawazoe N; Aiuchi T; Masuda Y; Nakajo S; Nakaya K
    J Biochem; 1999 Aug; 126(2):278-86. PubMed ID: 10423518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cardiotonic steroid bufalin-induced differentiation of THP-1 cells. Involvement of Na+, K(+)-ATPase inhibition in the early changes in proto-oncogene expression.
    Numazawa S; Inoue N; Nakura H; Sugiyama T; Fujino E; Shinoki M; Yoshida T; Kuroiwa Y
    Biochem Pharmacol; 1996 Jul; 52(2):321-9. PubMed ID: 8694857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy.
    Soumoy L; Genbauffe A; Mouchart L; Sperone A; Trelcat A; Mukeba-Harchies L; Wells M; Blankert B; Najem A; Ghanem G; Saussez S; Journe F
    Cancer Cell Int; 2024 Jan; 24(1):8. PubMed ID: 38178183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.